Testicular cancer is the most common cancer in men between the ages of 15 to 34. There are two different types of testicular cancer based on how the cells look under a microscope. The classifications are seminoma and non-seminoma testicular cancer.
Metastatic nonseminomatuous testicular cancer can be cured in many men with chemotherapy. Sometimes after the treatment the cancer returns. The journal BJU International published results that stated if men recur more than two years following chemotherapy it may prove to be different than cancer that recurs earlier, and may require different treatment options.
Researches in the UK did a study of men who had late relapse. They wanted to see if surgery could in fact have good outcomes on these men. The study concluded that if surgery is feasible it appears to improve survival.
